Ancient herbs take on obesity and joint pain: a new clinical trial
NCT ID NCT06859697
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This pilot study tests whether personalized herbal medicine can help obese adults with spinal or joint pain lose weight and reduce pain. Forty participants will receive either herbal treatment plus lifestyle guidance or lifestyle guidance alone. The study measures changes in BMI and body fat percentage over time.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- herbal medicine (complex extract of medicinal herbs prescribed by a Korean medicine doctor)
- What this could lead to
- If effective, this could offer a natural, drug-free option for managing obesity and related joint pain, potentially reducing the need for painkillers or surgery.
- What could go wrong
- This is a small pilot study with only 40 participants, so results may not apply broadly. Herbal medicines can vary in quality and may cause side effects or interact with other medications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 40 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2025
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
19 to 69 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients aged 19 years or older but under 70 years. * Individuals with a BMI of 25 kg/m² or higher, meeting the Asia-Pacific obesity criteria. * Individuals experiencing spinal or joint pain, with the most severe pain rated as NRS 5 or higher. * Individuals who voluntarily agree to participate in the clinical trial and sign the consent form. Exclusion Criteria: * Presence of findings on X-ray examination of the pain site, such as acute fractures or dislocations, requiring surgical intervention. * Diagnosis of specific diseases that may cause secondary obesity (e.g., Cushing's syndrome, hypothyroidism, insulinoma, adult growth hormone deficiency, etc.). * Current use of medications related to obesity treatment or a history of taking such medications within the past month. * Presence of other chronic diseases that may interfere with treatment efficacy or interpretation of results, such as stroke, myocardial infarction, kidney disease, active hepatitis, diabetic neuropathy, dementia, epilepsy, etc. * Current use of steroids, immunosuppressants, psychiatric medications, or other drugs that may affect study outcomes. * Unsuitability or safety concerns for herbal medicine treatment: individuals with conditions or post-surgical complications affecting drug absorption or digestion, severe liver disease, or kidney disease. * Pregnant or planning to become pregnant, or currently breastfeeding. * Participation in other clinical trials, except for observational studies without therapeutic intervention. * Difficulty in providing informed consent. * Other cases where the investigator deems participation in the clinical study inappropriate.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Obesity and overweight are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Jaseng Hospital of Korean Medicine
Seoul, Gangnam-Gu, 135-896, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New injection IBI3046 tested for weight management
- One-Size-Fits-All diets may be outdated: personalized plans put to the test
- Can timing your carbs tame metabolic risk?
- Home visits may boost heart health for pregnant women in nigeria
- Could a diabetes drug protect obese Teens' hearts?
- Could a biweekly shot rival weekly Weight-Loss drugs?